{"id":"W2567624910","doi":"10.1182/blood.v114.22.616.616","title":"A Phase II Trial Comparison of Once Versus Twice Weekly Bortezomib in CYBORD Chemotherapy for Newly Diagnosed Myeloma: Identical High Response Rates and Less Toxicity.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bortezomib; Medicine; Dexamethasone; Multiple myeloma; Regimen; Internal medicine; Cohort; Cyclophosphamide; Surgery; Toxicity; Gastroenterology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002014471,0.001091736,0.002412614,0.000471811,0.0003553089,0.0009568174,0.001017165,0.001444624,0.003412547],"category_scores_gemma":[0.001306124,0.0005580189,0.001013957,0.0004678241,0.001021991,0.0008096711,0.0003948447,0.00272558,0.0007107676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008597923,"about_ca_system_score_gemma":0.001206402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007109342,"about_ca_topic_score_gemma":0.00143382,"domain_scores_codex":[0.999379,0.0003649099,0.00003466902,0.0000983776,0.00004111256,0.00008190382],"domain_scores_gemma":[0.9987561,0.0002873254,0.0002206301,0.0001222917,0.00004854303,0.00056509],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9406366,0.02014333,0.001580845,0.0002675349,0.0004482811,0.00007310566,0.0000853418,0.0004709913,0.01254376,0.0001109241,0.0005730083,0.02306641],"study_design_scores_gemma":[0.7726282,0.2213125,0.003476959,0.00001775979,0.0001861223,0.00008833709,0.00001921236,0.0003726557,0.00117791,0.00008124903,0.0006270403,0.00001201651],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995266,0.001579624,0.000301243,0.0002428023,0.0002015687,0.001256394,0.0003203145,0.00004202742,0.0007900273],"genre_scores_gemma":[0.9933964,0.001175578,0.001042698,0.0004495981,0.0002235054,0.001522814,0.0008653671,0.00002008353,0.001304093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003412547,"threshold_uncertainty_score":0.01141608,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05429863549238061,"score_gpt":0.4000287091053771,"score_spread":0.3457300736129965,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}